Skip to main content

MoneyWorks4Me

Laurus Labs informs about company updates

19 Aug 2017 Evaluate

Laurus Labs has informed that US Food and Drug Administration (USFDA) has completed inspection of API facilities in Unit 1 and 3 in Parawada, Visakhapatnam, Andhra Pradesh, with two observations. This is a regular surveillance audit by USFDA, and the observations are procedural in nature and no data integrity issues were observed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1833.50
Dr. Reddys Labs. 1359.65
Cipla 1398.30
Lupin 1980.35
Zydus Lifesciences 1198.45
View more..